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Abstract Hermansky Pudlak syndrome (HPS) is a hetero-
geneous recessive genetic disease with a tendency to
develop lung Wbrosis with aging. A mouse strain with two
mutant HPS genes aVecting separate vesicle traYcking
pathways, C57BL/6-Hps1ep-Ap3b1pe, exhibits severe lung
abnormalities at young ages, including enlarged alveolar
type II (ATII) cells with giant lamellar bodies and foamy
alveolar macrophages (AMs), which are readily identiWed
histologically. In this study, the appearance of lung Wbrosis
in older animals was studied using classical histological
and biochemical methods. The HPS double mutant mice,
but not Chediak Higashi syndrome (C57BL/6-Lystbg-J-J,
CHS) or C57BL/6J black control (WT) mice, were found to
develop lung Wbrosis at about 17 months of age using Mas-
son trichrome staining, which was conWrmed by hydroxy-
proline analysis. TGF 1 levels were elevated in bronchial
alveolar lavage samples at all ages tested in the double
mutant, but not WT or CHS mice, indicative of a preWbrotic
condition in this experimental strain; and AMs were highly
positive for this cytokine using immunohistochemistry
staining. Prosurfactant protein C staining for ATII cells
showed redistribution and dysmorphism of these cells with
aging, but there was no evidence for epithelial-mesenchy-
mal transition of ATII cells by dual staining for prosurfac-
tant C protein and -smooth muscle actin. This
investigation showed that the HPS double mutant mouse
strain develops interstitial pneumonia (HPSIP) past 1 year
of age, which may be initiated by abnormal ATII cells and
exacerbated by AM activation. With prominent preWbrotic
abnormalities, this double mutant may serve as a model for
interventive therapy in HPS.
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Introduction
Hermansky Pudlak syndrome (HPS) is a heterogeneous
recessive genetic disease which aVects vesicle traYcking in
lysosome-related organelles, including melanosomes, plate-
let dense granules, and lamellar bodies in alveolar type II
(ATII) cells (Bonifacino 2004; Wei 2006). Some patients
with this disease develop pulmonary Wbrosis, also called HPS
interstitial pneumonia (HPSIP, Nakatani et al. 2000). HPSIP
is characterized by giant lamellar bodies of ATII cells and
their apparent degeneration, which is hypothesized to play a
major role in the development of this Wbrosing disorder.
There are some 14 mouse mutants that are animal mod-
els for HPS (Li et al. 2004). The mouse pale ear mutant,
HPS1ep, is the model for the most common HPS disease,
HPS 1, while the pearl mutant, Ap3b1pe, is the model for
HPS 2. As for all HPS genes, the products HPS1 and HPS2
(a subunit of the AP-3 adaptor complex, Feng et al. 1999),
respectively, are involved in vesicle traYcking and the
secretory process, and known to inXuence separate path-
ways (Feng et al. 2002). The HPS mouse strain, C57BL/
6-Hps1ep-Ap3b1pe, combines two mutant HPS genes into
one mouse model for HPS (Feng et al. 2002).
Previous study of this strain showed that, at 1 year of age
or younger, the lungs of these animals were Wlled with foamy
and binucleate alveolar macrophages (AMs), exhibited
emphysema, impaired lung ventilation, and giant lamellar
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bodies of ATII cells (Lyerla et al. 2003), that are not as
pronounced in the individual mutant strains (Feng et al.
2002). Thus, the mutant eVects of each gene on cellular secre-
tion were exaggerated in this double homozygote condition,
which resulted in abnormal perturbations of aVected cell
types, particularly ATII cells. Subsequent investigations
showed levels of phospholipid and surfactant proteins B and
C were highly elevated in lung homogenates, but decreased in
bronchial alveolar lavages (BAL, Guttentag et al. 2005), indi-
cating accumulated storage and blocked secretion for both
surfactant lipids and proteins of the ATII cells that accounted
for the giant lamellar bodies seen in these mutant cells.
The highly dysmorphic ATII cells in the HPS double
mutants were similar to those observed in HPSIP patients
(Nakatani et al. 2000), however, there was no evidence of
lung Wbrosis at these early ages (Lyerla et al. 2003). Studies
of lung morphology at the cellular and histological levels in
older ages, then, were needed to determine the possible
development of pulmonary Wbrosis with aging in this HPS
double mutant, which could be attributed to the cellular
defects in the secretory process caused by these mutations.
Abnormal lamellar bodies in ATII cells are also found in
another mouse mutant, beige (Lystbg, Lystbg), which is an
animal model for Chediak Higashi syndrome (CHS) (Chi
et al.  1975). This mouse strain exhibits accumulation of
surfactant in ATII cells, but shows normal secretion of sur-
factant phospholipids (Prueitt et al. 1978). Because of the
shared dysmorphism of ATII cells in the HPS double
mutant and CHS strains, the CHS mouse was also studied
in these investigations.
TGF 1 is considered to be the most important cytokine
for lung Wbrosis because it links possible causative processes
including inXammation and Wbroblast growth in the forma-
tion of this disease. Previous studies found this cytokine is
secreted from AMs in vitro (Nishimura et al. 2007) and
stimulated the diVerentiation and growth of myoWbroblasts
(Gu et al. 2007), the collagen producing cells in lung Wbro-
sis. TGF 1 administration can also induce epithelial–mes-
enchymal transition (EMT) (Kim et al. 2007; Liu 2004), a
process that appears important for lung Wbrosis (Kim et al.
2009). For these reasons, investigations of the time course of
TGF 1 secretion and localization of this cytokine in vivo
were made in conjunction with the histochemical and cellu-
lar analyses that assessed the development of pulmonary
Wbrosis in the HPS double mutant mouse strain.
Materials and methods
Mice
The breeding stock of C57BL/6-Hps1ep-Ap3b1pe, the dou-
ble mutant strain homozygous for two Hermansky Pudlak
Syndrome genes and referred to as the HPS double mutant,
was kindly provided by Dr. Richard Swank of the Roswell
Park Cancer Institute (BuValo, NY, USA). C57BL/6J
(wild type, or WT), and C57BL/6-Lystbg-J-J, the beige
mouse strain which is an animal model for Chediak Hig-
ashi Syndrome (CHS), were purchased from Jackson
Laboratories (Bar Harbor, ME, USA). All experimental
procedures were approved by the Institutional Animal
Care and Use Committee and followed the NIH Guidelines
for Laboratory. Mouse samples from the three strains were
free of infectious disorders as determined by Assessment
Plus (Charles River Laboratories, Wilmington, MA,
USA).
For biochemical and histological analyses, mice of given
ages were anesthetized with avertin, 1 mL of PBS bronchial
alveolar lavage (BAL) Xuid was transfused into cannulated
lungs three times, and 80% BAL Xuid was recovered. After
the lavage, the right lobes were separated with surgical
thread and snap frozen in liquid nitrogen for further analy-
sis. The left lung was fully inXated and Wxed in 4% buVered
formalin, embedded in paraYn, sectioned at 5 m, and
mounted on positively charged slides. After centrifugation,
the cell-free BAL supernatant was stored at ¡80°C for fur-
ther studies.
Hydroxyproline analysis
The method of Lazo (1981) was used for hydroxyproline
analyses from isolated right lobes. BrieXy, the lobes were
homogenized in 2 ml deionized water using either a
Dounce homogenizer or Polytron tissue grinder (Brinkman,
Lucern, Switzerland), and samples prepared from trichloro-
acetic acid precipitates were treated in 12 N HCl at 110°C
for 16 h and dissolved in 2 ml deionized water. Samples
and standards (50 l each) were incubated with Chloramine
T reagent for 20 min at room temperature, and with
Ehrlich’s reagent for 15 min at 65°C. The Wnal reaction
solutions were measured for absorbance at 550 nm (UV/
VIS spectrophotometer UV-1650PC, Shimadzu ScientiWc
Instruments, Columbia, MD, USA) and hydroxyproline
levels obtained as microgram per lung.
Alveolar size quantiWcation
Mean linear intercept (Lm) was employed to assess for
alveolar size according to Thurlbeck (1967). BrieXy, pho-
tomicrographs of hematoxylin stained sections were
divided into six identical squares by lines. Alveolar walls
crossing each line were counted, the counts were summed
for each print, and these were divided into the total length
of the lines crossing the photos in order to provide the
mean linear intercept value, Lm, for each photomicro-
graph. For this analysis, three photomicrographs wereHistochem Cell Biol (2010) 134:205–213 207
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made from separate regions across each lung section at
400£ magniWcation. Three mice were used from each of
the strains at six diVerent postnatal ages for a total of
some 162 diVerent photomicrographs (54 per strain). In
order to eliminate a possible subjective bias in this study,
four objective observers were employed to count the alve-
olar wall intercepts.
Immunohistochemistry (IHC)
IHC staining was done using a BenchMark® XT IHC/ISH
staining apparatus (Ventana Medical Systems, Inc, Tucson,
AZ, USA), according to the manufacturer’s detection XT
iVIEW DAB Open Kit with manual adjustments of the pro-
gram in order to accommodate mouse antigens. All anti-
bodies were freshly diluted with 2.5% goat serum (Jackson
ImmunoResearch Labs, Inc.). TGF 1 antibody (sc-146,
Santa Cruz Biotechnology, Santa Cruz, CA, USA) was
used at 1:200 dilution, prosurfactant protein C polyclonal
antibody (pro-spc, 20R-PR030, Fitzgerald Industries Int’l,
Concord, MA, USA) for ATII cell labeling at 1:3,000, and
biotinylated goat anti-rabbit secondary antibody (Jackson
ImmunoResearch) at 1:500. NonspeciWc staining was elimi-
nated by pretreatment with 2.5% goat serum and endoge-
nous biotin blocked by Blocker A/B reagents provided by
Ventana Medical Systems. Slides were counterstained by
hematoxylin followed by bluing reagent. Negative controls
were treated the same, only without the primary antibodies.
Fluorescent dual stainings for surfactant C and -smooth
muscle actin (-SMA) were performed by the core facility
in the Departments of Oncology and Pathology at the Johns
Hopkins Medical Institutions. BrieXy, the sections were
blocked in a mixture of Fab fragment of goat anti-mouse
IgG (Jackson ImmunoResearch), protein block solution
(Dako Cytomation, Carpinteria, CA, USA), normal goat
serum (Fitzgerald Industries Int’l), and bovine serum albu-
min (Sigma Chemicals, St. Louis, MO, USA). The primary
antibodies used were rabbit polyclonal anti-prosurfactant
protein C (Fitzgerald Industries Int’l) and mouse monoclonal
anti-smooth muscle actin (Dako Cytomation). Secondary
antibodies used were anti-rabbit Alexa-488 and anti-mouse
Alexa-610 (Molecular Probes Inc., Eugene, OR, USA).
Slides were counterstained by DAPI (Sigma Chemical
Co.).
ATII cell counting
Photomicrographs from prosurfactant protein C-stained
slides were analyzed by Image J software for the numbers
of ATII cells using the color deconvolution and analyze
particles function. The size was set larger than 220 square
pixels in order to avoid counting small non-cellular
particles.
Masson trichrome staining
This was done using commercially provided Masson Tri-
chrome Stain Kit (Richard-Allan ScientiWc, Kalamazoo,
MI, USA) according to the manufacturer’s protocols.
ELISA analysis
Total TGF 1 levels in BAL supernatants were tested by
ELISA assay (Promega, Madison, WI, USA), using acid
activated samples according to the manufacturer’s protocol.
Each sample was done in duplicate, and results reported as
pg TGF 1 per milliliter BAL.
Statistical analyses
The statistical analyses of strain diVerences at each age and
the age related trends of each mouse strain were performed
separately by the Tukey HSD test, using JMP software
(SAS Institute Inc., Cary, NC, USA). The criterion of sig-
niWcant diVerence was set at P < 0.05. Results are reported
as averages § standard deviations (§SD).
Results
Lung Wbrosis in HPS double mutant mice
At 12 months of age, large areas of blue Masson trichrome
stained collagen were observed in the alveolar epithelium
in HPS (Fig. 1a). At 17 months, sections from HPS double
mutants had intensely stained blue collagen in association
with thickened alveolar walls and tissue patches, the classi-
cal histological presentation of lung Wbrosis (Fig. 1b). In
contrast, WT and CHS histological samples from all ages
tested were devoid of the concentrated blue staining
regions, indicative of the lack of collagen deposition in
these two mice strains (Fig. 1c, d). At the ages from 2 to
9 months, there was no concentrated blue staining in the
lung sections from the three mouse strains (data not
shown).
The level of lung Wbrosis was quantiWed by hydroxypro-
line analyses in the three strains from 2 to over 17 months
of age (Fig. 1e). Results indicated that lung Wbrosis in the
HPS double mutant at 17 months of age was prominent,
which was consistent with the observations from Masson
trichrome stained lung sections.
HPS lungs also exhibited signiWcantly larger alveoli
compared with WT and CHS at all ages tested, indicative of
emphysema (Fig. 1f) and consistent with previous studies
of this strain (Lyerla et al. 2003). The enlargement of alve-
oli became more severe after 12 months of age, when lung
Wbrosis was observed.208 Histochem Cell Biol (2010) 134:205–213
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Changes of distribution and morphology in AT II cells 
in HPS double mutant mice with aging
From the lung sections stained for prosurfactant C, ATII
cells exhibited a homogeneous distribution in HPS double
mutant mice at 2 months of age (Fig. 2a), where 1–3 ATII
cells were found per alveolus. A change in this distribution
was observed in samples from 5 month old mutants, where
these cells appeared sparsely scattered and no longer pres-
ent among all alveoli (Fig. 2b). At 9 months of age, ATII
cell-rich regions were observed, and with some devoid of
this cell type (Fig. 2c). Compared with these observations,
ATII cells in WT and CHS samples at all ages tested were
evenly distributed among all alveoli (Fig. 2d, e). The quan-
tiWcation of ATII cells showed that there was a signiWcant
cell number decrease at 5 months of age and a recovery of
the cell number at the age of 9 months in the HPS strain
(Fig. 2f). As the alveolar sizes were stable from 2 to
9 months of age in HPS (Fig. 1f), the change in ATII cell
number represented an absolute reduction in the numbers of
this cell type in 5 month old HPS lungs. Compared with
HPS, ATII cell numbers in WT mice were constant at all
ages tested. CHS ATII cells showed non-signiWcant but a
trend of decreasing in number with aging (Fig. 2g).
Fig. 1 Histochemical and bio-
chemical analyses of the lung 
Wbrosis in aging HPS double 
mutant mice. Panels a–d are rep-
resentative photomicrographs of 
Masson trichrome stained lung 
sections from a HPS at 
12 months of age, b HPS at 
17 months, c WT at 17 months, 
and d CHS mice at 17 months. 
Panel e shows the lung hydroxy-
proline levels (§SD) in HPS, 
WT, and CHS mice with aging; 
panel f shows the mean linear 
intercepts (Lm, §SD) of the 
lungs from HPS, WT, and CHS 
with aging. Samples of 3–6 mice 
were used for each time category 
and strain. Mouse strains: 
HPS = HPS double mutant 
mouse, C57BL/6-Hps1ep-
Ap3b1pe; CHS = CHS mouse, 
C57BL/6-Lystbg-J-J; WT = wild 
type mouse, C57BL/6J. SigniW-
cant diVerence P < 0.05: *HPS 
versus WT; #HPS versus CHS. 
No signiWcant diVerence 
between CHS and WT was 
found at any age testedHistochem Cell Biol (2010) 134:205–213 209
123
In addition to their distribution, the morphology of ATII
cells in HPS changed with aging. These cells were elon-
gated along the alveolar walls in the double mutant at
1 year old and beyond (Fig. 3a, b), when it was not possible
to assess the number of ATII cells/alveolus in HPS. ATII
cells in WT and CHS lungs showed no obvious changes in
shape (data not shown).
The aggregation and dysmorphism of HPS ATII cells at
later ages suggested an EMT process in this cell type. How-
ever, the dual stainings for ATII cell marker surfactant C
and myoWbroblast marker -SMA did not exhibit co-stain-
ing (Fig. 4). Instead, the possible myoWbroblasts with
-SMA staining and clusters of ATII cells both appeared
around the thickened alveolar walls and Wbrotic patches
(Fig. 4a, b).
TGF 1 in HPS double mutant mice
As seen in Fig. 5a, signiWcantly higher levels of TGF 1 in
HPS BAL supernatants were found at all ages tested,
Fig. 2 ATII cell distribution 
changes with aging in HPS dou-
ble mutant mice. Representative 
prosurfactant C-stained (brown 
precipitate) lung sections using 
IHC from HPS mice at a 
2 months, b 5m o n t h s ,  c 
9 months, and d WT and e CHS 
at the age of 12 months. The 
ATII cells in HPS and CHS mu-
tants are both enlarged com-
pared with WT mice. Panel f 
shows the average ATII cell 
number per photomicrograph in 
HPS double mutant mice at the 
age of 2, 5, and 9 months. ATII 
cell number at 5 months of age is 
signiWcantly lower than those at 
2 and 9 months old (asterisk). 
Panel g shows the average ATII 
cell number per photomicro-
graph in WT and CHS mice 
from 2 months to 17 months of 
age. The cell density was con-
stant in WT mice, but showed a 
non-signiWcant decrease in CHS 
mice210 Histochem Cell Biol (2010) 134:205–213
123
compared with WT and CHS. Also, TGF 1 levels in HPS
BAL were signiWcantly higher at 17 months than those at
9 months of age. Dense staining using IHC for this cytokine
was found in AMs of the HPS double mutants as well as
WT control and CHS mouse strain throughout all ages
tested. Dark staining was observed in cells of the alveolar
walls in HPS mice at 12 and 17 months of age, but not in
WT or CHS mice (Fig. 5b–e).
Discussion
This research was undertaken in order to determine whether
the HPS double mutant mice exhibited classical signs of
lung Wbrosis with aging beyond 1 year of age. Some 300 or
more post-natal animals were examined for this study,
including 131 HPS double mutants. Twenty-seven HPS
mice 16 WT and 18 CHS were raised to 17 months of age
or older. Among these, none of the WT control or CHS
animals exhibited classical signs of Wbrosis as evidenced by
high levels of hydroxyproline or the presence of Wbrotic
patches, while 20 (74%) of the double mutant animals at
17 months and beyond had one or both of these symptoms.
Most importantly, perhaps, the lung abnormalities in HPS
mice, including lung Wbrosis, are unlike those induced by
drugs (Borzone et al. 2001), i.e., they are progressive until
the end of the animals’ lives and do not heal with time.
Masson trichrome staining and hydroxyproline analysis
both detected lung Wbrosis in this double mutant at the age
of 17 months. The histological method appeared to be more
sensitive in detecting collagen deposition in lungs. That is,
at 12 months of age, Masson trichrome staining showed
obvious blue staining in the alveolar walls, which was not
found in WT and CHS mouse strains or HPS at younger
ages. Hydroxyproline levels, however, were not signiW-
cantly diVerent among these three strains at that age. This
may be because pulmonary Wbrosis starts as deposition in
alveolar walls with insuYcient amounts of collagen to
aVect the whole lung analysis of hydroxyproline levels.
Also, hydroxyproline analysis can be aVected by the
increased levels of surfactant proteins in ATII cells (Lyerla
et al. 2003), which explains the slightly higher levels seen
in HPS and CHS mice at younger ages.
Many lung abnormalities including emphysema, dys-
morphic and highly activated AMs (Lyerla et al. 2003), and
higher levels of TGF 1 (this study), appeared much earlier
than the overt Wbrosis in the HPS double mutant animals.
All of these abnormalities were more severe at 12 months
of age, when the alveolar interstitium was thickened with
collagen and lined with ATII cells. Thus, the lung abnor-
malities of HPS double mutant can be separated into two
stages: the preWbrotic, in which early abnormalities are
observed and persist to 9 months of age; and accelerated
deterioration, after 9 months of age when these symptoms
increase in severity as either the causes or eVects of devel-
oping Wbrosis.
The preWbrotic stage in the HPS double mutant may be
useful for studies of early diagnosis and therapeutic inter-
ventions of HPSIP. For example, the changes of ATII cell
distributions and decrease in number observed in HPS dou-
ble mutant from 2 to 9 months of age were unique. This
was not observed in earlier studies (Lyerla et al. 2003) and
is presumably not detectable in bleomycin-induced animals
due to the rapid nature of developing Wbrosis in this model.
The decrease of ATII cells in HPS lungs from 2 to
5 months may be due to the abnormal structure of this cell
type with giant lamellar bodies. This might also be the rea-
son for the trend of ATII cell decreasing in CHS mice with
similar but less enlarged giant lamellar bodies. The increase
of ATII cell numbers in HPS lungs at 9 months and beyond
may be due to proliferation induced by mechanical stress as
lung structure deteriorates. This phenomenon has been
Fig. 3 Representative prosurfactant protein C-stained lung sections
from HPS mice at postnatal ages of a 12 and b 17 months. Note the
aggregated and misshapen ATII cells in HPS double mutant mice seen
at these older agesHistochem Cell Biol (2010) 134:205–213 211
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found in ATII cells of mice during compensatory regrowth
after single lung pneumonectomy (HoVman et al. 2010).
The persistent presence of abnormally high levels of
total TGF 1 which was seen in BAL samples and localized
in AMs by IHC staining, is another preWbrotic condition.
This cytokine was mainly localized to AMs, suggesting this
cell type is its major source, which is in keeping with other
studies using chemically induced animal models (Chen
et al. 2009 Nishimura et al. 2007). Previous studies have
shown that the deWciency of surfactant protein B in mice
promoted AM activation (Ikegami et al. 2005). Thus, the
blocked secretion of surfactant proteins in HPS mice
(Guttentag et al. 2005) may increase TGF 1 secretion by
activation of AMs. This hypothesis is also supported by the
studies of CHS mouse strain, which also possesses enlarged
lamellar bodies in ATII cells but exhibits normal surfactant
lipid secretion of ATII cells (Prueitt et al. 1978) and, in this
study, showed no increased levels of TGF 1 in BAL sam-
ples with aging. On the basis of histological analyses, Tang
et al. (2005) reported that CHS (Lystbg) mice exhibited a
more robust Wbrosis than seen in the HPS1 mouse model,
C57/B6 HPS1ep. Our results do not conWrm this observation
regarding the appearance of pulmonary Wbrosis in the CHS
strain. Intra-strain variation and environmental factors may
account for this discrepancy. However, the similar levels of
TGF 1 and hydroxyproline observed in the lungs of CHS
compared with WT mice in our laboratory were consistent
with the histological assessment of the lack of Wbrotic
patches in the CHS animals at all ages tested. It is also
consistent with CHS patients who are not at risk for lung
Wbrosis (Intone et al. 2009).
The appearance of TGF 1 in epithelial cells in lungs
from HPS mice older than 1 year indicated a possible sec-
ondary source of this cytokine. This change coincided with
an increase of TGF 1 in BAL which suggests that addi-
tional cell types contribute TGF 1 levels when HPS mice
enter the accelerated deterioration period.
Although the role of TGF 1 in the development of lung
Wbrosis is well established, there are still questions about
the importance of EMT in this process. For example, Kim
et al. (2009) created a transgenic mouse strain that perma-
nently expressed GFP in prosurfactant C positive cells, and
found colocalization of -SMA and GFP after bleomycin
treatment. KönigshoV et al. (2009) also found -SMA
expression in ATII primary cell cultures from bleomycin
treated mice. In this study, when single DAB staining of
-SMA was used, some positively stained cells were
observed with ATII cell morphology in HPS double mutant
mice at old ages (data not shown). However, the Xuorescent
double staining method did not support EMT in ATII cells.
This is similar to the work of Yamada et al. (2008) who
showed no evidence of EMT using dual IHC staining of
epithelial markers and myoWbroblast markers, including
-SMA, in bleomycin treated mice. These inconsistencies
may be because either the sensitivity of antibody staining is
aVected by double staining in animal tissues or that, in
single staining, ATII cells from Wbrotic lungs absorb the
reactive antibody and cause false positives. In this
Fig. 4 Representative prosurf-
actant protein C (strong green, 
shown by arrow heads) and 
-SMA-stained (pink, shown by 
arrows) lung sections from HPS 
mice at postnatal ages of a 12, 
b 17 months with a Wbrotic area, 
Lung sections of WT c and CHS 
d mice at 17 months of age. 
Arrow heads showed representa-
tive ATII cells which were 
stained strong green, and arrows 
showed representative myoW-
broblasts which were stained 
pink. Highly positive -SMA 
cells were found in close prox-
imity to aggregations of ATII 
cells at 12 months and 
17 months of age in HPS double 
mutant mice, but this marker 
was not co-localized with that of 
prosurfactant C protein. Fewer 
myoWbroblasts were found in 
WT and CHS. Walls of bronchi-
oles and blood vessels were also 
stained with -SMA marker212 Histochem Cell Biol (2010) 134:205–213
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investigation, the morphological changes observed in ATII
cells of HPS mice with aging suggested that the cells under-
went some conversion, but whether this involves EMT
needs additional study. If this conversion is not due to
EMT, these cells may diVerentiate into alveolar type I
(ATI) cells in order to compensate for lung destruction. The
abnormal prosurfactant C staining in HPS compared with
WT mice may be due to diYculty in surfactant clearance in
HPS ATII cells compared with WT. This hypothesis could
be conWrmed by double staining of prosurfactant C and ATI
cell markers in our future studies.
The presence of Wbrotic patches and elevated levels of
hydroxyproline with aging, and the persistently high levels
of TGF-1 in alveoli of these mice, versus the absence of
these features in the WT control and CHS strain provide
evidence for progressive HPSIP in the double mutant
strain. As this has not been reported for either of the single
HPS mutant animals from which the HPS double mutant
strain was derived, it appears that the combination of two
vesicle traYcking disorders aVecting separate pathways is
especially injurious to long-term maintenance of lung
homeostasis. The lung cell abnormalities that are known in
this strain include the presence of giant lamellar bodies in
ATII cells (Lyerla et al. 2003) resulting in the block to
secretion of surfactant protein (Guttentag et al. 2005) and,
from this study, the high levels of alveolar TGF-1 mainly
due to activated AMs. It appears that the blocked secretion
of ATII cells induces AM activation and lung stresses such
as alveolar destruction. The lung stresses may trigger a
compensatory response including ATII cell regrowth. The
activated AMs, which secrete high levels of TGF 1, and
ATII cells, which show morphological cell conversion, lead
the lung into progressive HPSIP in this strain.
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Fig. 5 TGF 1 BAL levels and 
localization in lungs. Panel a 
shows average TGF 1 (§SD) 
levels in BAL samples of HPS, 
WT, and CHS mice from 2 to 
17 months of age using ELISA. 
Samples of 4–10 mice were used 
for each time point and strain. 
SigniWcant diVerence P < 0.05: 
*HPS versus WT; #HPS versus 
CHS. No signiWcant diVerence 
between CHS and WT was 
found at any age tested. Panels 
b–e are representative TGF 1 
IHC stained (brown precipitate) 
lung sections from HPS at (b) 9 
and (c) 12 months of age and 
from (d) WT and (e) CHS at 
12 months of age. AMs (intra-
alveolar cells) were darkly 
stained in each of the mouse 
strains at all ages tested, and 
staining appeared in epithelial 
cells as well in older HPS mice 
but not in WT or CHS miceHistochem Cell Biol (2010) 134:205–213 213
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